SE8602530L - Nasala farmaceutiska kompositioner - Google Patents

Nasala farmaceutiska kompositioner

Info

Publication number: SE8602530L
Authority: SE; Sweden
Prior art keywords: pharmaceutical compositions; nasal pharmaceutical; nasal; calcitonin; peptides
Prior art date: 1985-06-04

Application number

SE8602530A

Other languages

English (en)

Swedish (sv)

Other versions

SE8602530D0 (sv

Inventor

M Azria

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-04

Filing date

1986-06-04

Publication date

1986-12-05

1986-06-04 Application filed by Sandoz Ag filed Critical Sandoz Ag

1986-06-04 Publication of SE8602530D0 publication Critical patent/SE8602530D0/xx

1986-12-05 Publication of SE8602530L publication Critical patent/SE8602530L/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Endocrinology (AREA)
Otolaryngology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SE8602530A 1985-06-04 1986-06-04 Nasala farmaceutiska kompositioner SE8602530L (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB858514090A GB8514090D0 (en)	1985-06-04	1985-06-04	Organic compounds

Publications (2)

Publication Number	Publication Date
SE8602530D0 SE8602530D0 (sv)	1986-06-04
SE8602530L true SE8602530L (sv)	1986-12-05

Family

ID=10580163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8602530A SE8602530L (sv)	1985-06-04	1986-06-04	Nasala farmaceutiska kompositioner

Country Status (21)

Country	Link
US (1)	US4988512A (xx)
JP (1)	JPS61282320A (xx)
KR (1)	KR870000066A (xx)
AU (1)	AU5824786A (xx)
BE (1)	BE904863A (xx)
CH (1)	CH668913A5 (xx)
DE (1)	DE3617728A1 (xx)
DK (1)	DK259186A (xx)
ES (1)	ES8801130A1 (xx)
FR (1)	FR2582511B1 (xx)
GB (3)	GB8514090D0 (xx)
GR (1)	GR861422B (xx)
HU (1)	HU199300B (xx)
IL (1)	IL78980A0 (xx)
IT (1)	IT1214683B (xx)
LU (1)	LU86457A1 (xx)
NL (1)	NL8601285A (xx)
NZ (1)	NZ216393A (xx)
PT (1)	PT82691B (xx)
SE (1)	SE8602530L (xx)
ZA (1)	ZA864164B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH657779A5 (de) *	1982-10-05	1986-09-30	Sandoz Ag	Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) *	1986-08-18	1988-03-03	Sandoz Ag	Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) *	1986-12-23	1992-06-17	Ciba Geigy Ag	Nasal solutions
US5690954A (en) *	1987-05-22	1997-11-25	Danbiosyst Uk Limited	Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8712176D0 (en) *	1987-05-22	1987-06-24	Cosmas Damian Ltd	Drug delivery system
GB8723846D0 (en) *	1987-10-10	1987-11-11	Danbiosyst Ltd	Bioadhesive microsphere drug delivery system
US5026825A (en) *	1988-09-08	1991-06-25	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Intranasal calcitonin formulations
GB9020544D0 (en) *	1990-09-20	1990-10-31	Sandoz Ltd	Improvements in or relating to organic compounds
HU222249B1 (hu) *	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) *	1991-05-15	1992-11-19	Lohmann Therapie Syst Lts	Penetrationsfoerdernde substanz
EP0586589B1 (en) *	1991-05-24	1997-08-20	Amylin Pharmaceuticals, Inc.	Amylin or amylin analogue composition optionally containing insulin for the treatment of anorexia and related states
DE4140192C2 (de) *	1991-12-05	1996-02-29	Alfatec Pharma Gmbh	Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
ES2108258T3 (es) *	1992-01-17	1997-12-16	Alfatec Pharma Gmbh	Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.
HUT75616A (en) *	1992-03-17	1997-05-28	Pfizer	Method for prooucing porous delivery devices
GB9623205D0 (en) *	1996-11-07	1997-01-08	Eurand Int	Novel pharmaceutical compositions
EP1061987B1 (en)	1998-02-13	2006-05-17	Bioniche Life Sciences Inc.	Drug delivery system
TWI243687B (en) *	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
US6759393B1 (en)	1999-04-12	2004-07-06	Pfizer Inc.	Growth hormone and growth hormone releasing hormone compositions
WO2004084859A2 (en)	2003-03-21	2004-10-07	Nastech Pharmaceutical Company Inc.	Nasal calcitonin formulations containing chlorobutanol
WO2005097210A1 (en) *	2004-03-26	2005-10-20	The University Of Utah Research Foundation	Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en)	2004-11-09	2008-07-08	Kemia, Inc.	Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US820948A (en) *	1905-01-23	1906-05-22	Edward Baum	Device fot treating the nasal passages.
US3234091A (en) *	1955-07-08	1966-02-08	Ciba Geigy Corp	Shaped medicaments and process for their manufacture
DE1617564A1 (de) *	1966-12-03	1971-04-01	Rudolf Kisro	Arzneimitteltraeger
DK135268A (xx) *	1973-02-09
GB1548022A (en) *	1976-10-06	1979-07-04	Wyeth John & Brother Ltd	Pharmaceutial dosage forms
US4164560A (en) *	1977-01-05	1979-08-14	Folkman Moses J	Systems for the controlled release of macromolecules
US4391797A (en) *	1977-01-05	1983-07-05	The Children's Hospital Medical Center	Systems for the controlled release of macromolecules
GB2042888B (en) *	1979-03-05	1983-09-28	Teijin Ltd	Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) *	1979-07-31	1985-08-12	帝人株式会社	持続性鼻腔用製剤およびその製造法
JPS56100714A (en) *	1980-01-16	1981-08-12	Teijin Ltd	Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) *	1980-06-12	1982-01-13	Toshiba Corp	Recording and reproducing device
GB2090535B (en) *	1981-01-06	1984-09-19	Osman Mohammad Fekry	Medical inserts
JPS5921613A (ja) *	1982-07-28	1984-02-03	Takeda Chem Ind Ltd	直腸投与製剤
GB2127689B (en) *	1982-10-05	1986-07-09	Sandoz Ltd	Calcitonin inhalation compositions
US4452775A (en) *	1982-12-03	1984-06-05	Syntex (U.S.A.) Inc.	Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) *	1982-12-17	1986-12-19	Sandoz Sa	Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) *	1982-12-29	1984-03-30	Armour Pharma	Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) *	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	徐放型マイクロカプセルの製造法
US4591496A (en) *	1984-01-16	1986-05-27	Massachusetts Institute Of Technology	Process for making systems for the controlled release of macromolecules

1985
- 1985-06-04 GB GB858514090A patent/GB8514090D0/en active Pending
1986
- 1986-05-21 HU HU862159A patent/HU199300B/hu unknown
- 1986-05-21 NL NL8601285A patent/NL8601285A/nl not_active Application Discontinuation
- 1986-05-27 CH CH2137/86A patent/CH668913A5/de not_active IP Right Cessation
- 1986-05-27 DE DE19863617728 patent/DE3617728A1/de not_active Ceased
- 1986-06-02 GR GR861422A patent/GR861422B/el unknown
- 1986-06-02 GB GB8613284A patent/GB2176105B/en not_active Expired - Lifetime
- 1986-06-02 IL IL78980A patent/IL78980A0/xx unknown
- 1986-06-02 KR KR1019860004329A patent/KR870000066A/ko not_active Ceased
- 1986-06-02 AU AU58247/86A patent/AU5824786A/en not_active Abandoned
- 1986-06-02 PT PT82691A patent/PT82691B/pt unknown
- 1986-06-02 DK DK259186A patent/DK259186A/da not_active Application Discontinuation
- 1986-06-03 JP JP61130010A patent/JPS61282320A/ja active Pending
- 1986-06-03 FR FR868607979A patent/FR2582511B1/fr not_active Expired
- 1986-06-03 BE BE1/011501A patent/BE904863A/fr not_active IP Right Cessation
- 1986-06-03 ES ES555676A patent/ES8801130A1/es not_active Expired
- 1986-06-03 NZ NZ216393A patent/NZ216393A/xx unknown
- 1986-06-04 IT IT8648098A patent/IT1214683B/it active
- 1986-06-04 LU LU86457A patent/LU86457A1/fr unknown
- 1986-06-04 ZA ZA864164A patent/ZA864164B/xx unknown
- 1986-06-04 SE SE8602530A patent/SE8602530L/xx not_active Application Discontinuation
1989
- 1989-03-22 GB GB8906584A patent/GB2213377A/en not_active Withdrawn
- 1989-09-18 US US07/408,641 patent/US4988512A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPS61282320A (ja)	1986-12-12
GB8613284D0 (en)	1986-07-09
NZ216393A (en)	1989-08-29
DK259186A (da)	1986-12-05
PT82691A (en)	1986-07-01
SE8602530D0 (sv)	1986-06-04
HU199300B (en)	1990-02-28
DK259186D0 (da)	1986-06-02
PT82691B (en)	1988-05-03
FR2582511A1 (fr)	1986-12-05
GB8514090D0 (en)	1985-07-10
GB2176105A (en)	1986-12-17
HUT49288A (en)	1989-09-28
GB2176105B (en)	1990-03-07
IT8648098A0 (it)	1986-06-04
GB8906584D0 (en)	1989-05-04
LU86457A1 (fr)	1987-01-13
AU5824786A (en)	1986-12-11
FR2582511B1 (fr)	1989-05-26
GR861422B (en)	1986-10-01
ZA864164B (en)	1988-01-27
GB2213377A (en)	1989-08-16
KR870000066A (ko)	1987-02-16
CH668913A5 (de)	1989-02-15
NL8601285A (nl)	1987-01-02
IT1214683B (it)	1990-01-18
ES555676A0 (es)	1988-01-01
BE904863A (fr)	1986-12-03
DE3617728A1 (de)	1986-12-04
ES8801130A1 (es)	1988-01-01
US4988512A (en)	1991-01-29
IL78980A0 (en)	1986-09-30

Publication	Publication Date	Title
SE8602530L (sv)	1986-12-05	Nasala farmaceutiska kompositioner
FI20010334L (fi)	2001-02-21	Granulosyyttipesäkkeitä stimuloivia polypeptidejä, niitä sisältävä farmaseuttinen koostumus, ja niiden lääketieteellinen käyttö
DK165730C (da)	1993-06-07	Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DE3776946D1 (de)	1992-04-09	Nasale verabreichung von arzneimitteln.
FI943565L (fi)	1994-07-29	Uusia veren hyytymistä estäviä polypeptidejä, niiden valmistus ja niitä sisältävä farmaseuttinen koostumus
IE862554L (en)	1987-03-27	Pharmaceutical compositions
PT81969A (de)	1986-03-01	11beta-phenyl-gonane deren herstellung und diese enthaltende pharmazeutische praparate
DE3688710D1 (de)	1993-08-26	Isolierung und pharmazeutische verwendung von hyaluronidase und diese enthaltende pharmazeutische und tieraerztliche praeparate.
GB2181346B (en)	1989-10-04	Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
NZ218473A (en)	1990-03-27	Calcitonin derivatives and pharmaceutical compositions
FR2577557B1 (fr)	1990-05-11	Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant
ZA862416B (en)	1988-04-27	Composition for delivery of orally administered drugs and other substances
DE3583765D1 (de)	1991-09-19	Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
BR8907708A (pt)	1991-07-30	Composicoes farmaceuticas compreendendo calcitonina para administracao intranasal e uma unidade de aerossol para administracao das mesmas
FI864164A7 (fi)	1987-04-18	Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
IT8468281A1 (it)	1986-06-27	Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
MC1847A1 (fr)	1988-09-30	Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
IT8521322A0 (it)	1985-06-27	Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
DK52086D0 (da)	1986-02-03	Farmaceutiske praeparater indeholdende ergotalkaloider
FR2530624B1 (fr)	1987-08-07	Nouveaux analogues de la vitamine d et compositions pharmaceutiques ou veterinaires les contenant
ES2037807T3 (es)	1993-07-01	Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
IT1223132B (it)	1990-09-12	Composizione farmaceutica per somministrazione nasale
DE3671630D1 (de)	1990-07-05	Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
FI883730A7 (fi)	1989-02-15	Eetterit ja tioeetterit, joilla on terapeuttinen vaikutus, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
NL185666C (nl)	1990-06-18	Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.

Legal Events

Date	Code	Title	Description
1995-02-28	NAV	Patent application has lapsed	Ref document number: 8602530-1 Effective date: 19910101

Date

Code

Title

Description

1995-02-28

NAV

Patent application has lapsed

Ref document number: 8602530-1

Effective date: 19910101